Revvity Inc. (RVTY) Stock Analysis

Revvity Inc. (RVTY) is a publicly traded company in the HEALTHCARE sector. It trades at $100.52, carries a market capitalization of $11.21B, a price-to-earnings ratio of 48.33. This page summarizes the public market data, fundamentals, and frequently asked questions for RVTY, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NYSE

Key Metrics

• Price: $100.52
• Market Cap: $11.21B
• P/E Ratio: 48.33
• EPS: $2.08
• 52-Week High: $118.21
• 52-Week Low: $81.19

Market Sentiment

Revvity Inc. currently has a Neutral sentiment score of 0.12.

About Revvity Inc.

Revvity, Inc. is a leading provider of innovative products and solutions tailored for the diagnostics, life sciences, and applied services markets on a global scale. Headquartered in Waltham, Massachusetts, the company leverages cutting-edge technology to enhance diagnostic processes and improve overall healthcare outcomes. With a focus on delivering high-quality services and solutions, Revvity is well-positioned to capitalize on the growing demand for advanced diagnostic tools and life scien...

GNG Research Analysis

GNG Research scores Revvity Inc. (RVTY) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for RVTY.

Frequently Asked Questions

Does RVTY pay dividends?

Revvity Inc. (RVTY) does not currently pay a regular dividend.

What is RVTY's P/E ratio?

Revvity Inc. has a price-to-earnings (P/E) ratio of 48.33.

What is RVTY's market cap?

Revvity Inc. (RVTY) has a market capitalization of $11.21B with a current stock price of $100.52.